Showing results (1771-1780 of 2,107) with videos related to

Sort By:
Pageof 211
CNS Drugs|March 23, 2019
Targeting Inflammatory Pathways in Alzheimer's Disease: A Focus on Natural Products and PhytomedicinesMatthew J Sharman, Giuseppe Verdile, Shanmugam Kirubakaran, et al.
CNS Drugs|February 8, 2014
Catatonia in patients with autism: prevalence and managementLuigi Mazzone, Valentina Postorino, Giovanni Valeri, et al.
CNS Drugs|February 8, 2014
Cognitive effects of statin medicationsBrendan J Kelley, Stephen Glasser
CNS Drugs|April 12, 2017
Cell Therapy for Multiple SclerosisPamela Sarkar, Claire M Rice, Neil J Scolding
CNS Drugs|January 23, 2017
Safinamide: A Review in Parkinson's DiseaseHannah A Blair, Sohita Dhillon
CNS Drugs|June 13, 2008
Impact of newer pharmacological treatments on quality of life in patients with Parkinson's diseaseDavid A Gallagher, Anette Schrag
CNS Drugs|September 2, 2019
Subjective Versus Objective Outcomes of Antipsychotics for the Treatment of Neuropsychiatric Symptoms Associated with DementiaEline J Vredeveld, Tessa A Hulshof, Sytse U Zuidema, et al.
CNS Drugs|September 2, 2019
Apomorphine for Parkinson's Disease: Efficacy and Safety of Current and New FormulationsFederico Carbone, Atbin Djamshidian, Klaus Seppi, et al.
CNS Drugs|July 4, 2015
Targeting CGRP: A New Era for Migraine TreatmentStephanie Wrobel Goldberg, Stephen David Silberstein
CNS Drugs|April 21, 2015
Long-Term Treatment with Extended-Release Carbidopa-Levodopa (IPX066) in Early and Advanced Parkinson's Disease: A 9-Month Open-Label Extension TrialCheryl H Waters, Paul Nausieda, Lyudmila Dzyak, et al.
Pageof 211